Company / Inventory per Share
Xeris Biopharma Holdings, Inc. Inventory per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory per Share
$0.46
FY2025
5-year range
$0.20 / $0.46
FY2021-FY2025
Trend
+31.8%
vs FY2024
Sector context
#59 of 105
Health Care
What the data says
At $0.46, Xeris Biopharma Holdings, Inc.'s inventory per share ranks #59 of 105 in the Health Care sector. Inventory per Share has increased for 3 consecutive years, from $0.20 in FY2022 to $0.46 in FY2025.
Based on SEC 10-K filings.
0.46 in FY2025 with a 5-year CAGR of +18.6%.
Improved from $0.29 to $0.46 over the past 2 years.
Health Care sector context is included.
Inventory per Share over time
Growth rates
- 3-Year CAGR
- +32.4%
- 5-Year CAGR
- +18.6%
- 10-Year CAGR
- -
Sector benchmark
#59 of 105 in Health CareTop 56% of 105This company $0.46 Sector average $30.82
▼
-98.5% below sector average
Key checks
Key Insights
- Xeris Biopharma Holdings, Inc.'s inventory per share has grown for 3 consecutive years.
- In FY2025, inventory per share increased 31.8% year-over-year.
- Ranks #59 out of 105 companies in the Health Care sector.
- Lowest inventory per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.26 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Inventory per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.46 | +31.8% |
| FY2024 | $0.35 | +22.4% |
| FY2023 | $0.29 | +43.9% |
| FY2022 | $0.20 | -53.4% |
| FY2021 | $0.42 | +116.9% |
| FY2020 | $0.20 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026